Views & Analysis Unlocking the potential in rare disease research with decent... A survey by rare disease patient network Raremark found that 86% of the community members asked were interested in taking part in clinical trials.
Views & Analysis A collaborative approach to greater diversity in clinical tr... The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.
Views & Analysis Enabling new models of care: pursuing pharma’s partnership p... There is a huge, ongoing shift in how health and wellness is approached in the UK, and the changes will have important implications for NHS-industry partnerships.
Views & Analysis ‘No going back’ for clinical trials after COVID Trial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as a result.
Views & Analysis How patient insights are changing trial solutions Patients have been asking for patient-centric trial solutions for years – the industry just hasn’t been listening.
Views & Analysis True patient-focused research through decentralised and hybr... How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.